At least 17 biotechs and pharmas are slated to report earnings this week. Illumina Inc. (NASDAQ:ILMN) and The Medicines Co. (NASDAQ:MDCO) are expected to post quarterly EPS growth of more than 75%. Illumina, which markets genomic tools and services, is forecast to report revenue growth of 21% to $285 million. 3Q12 revenues for cardiovascular company Medicines Co. are expected to increase 13% to $137 million